Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2010 1
2013 2
2014 4
2015 4
2016 4
2017 7
2018 5
2019 5
2020 19
2021 15
2022 16
2023 15
2024 26
2025 26
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Five-Year Real-World Hard Outcomes of Vedolizumab in Inflammatory Bowel Disease: The IG-IBD LONG-LIVE Study.
Privitera G, Palumbo F, Macaluso FS, Laterza L, Pardi V, Viola A, Noviello D, Barberio B, Ricci C, Balestrieri P, Cappello M, Maconi G, Sablich R, Variola A, Bennato R, Pastorelli L, Grossi L, Ribaldone DG, Buda A, Bossa F, Di Sario A, Viscido A, Neri B, Mocci G, Pagnini C, Principi MB, Coletta M, Petruzzellis C, Mazzuoli S, Festa S, Mirarnda A, Bezzio C, Fanigliulo L, Rocco G, Pont ED, Spagnuolo R, Savarino EV, Caprioli FA, Fries W, Ceccarelli L, Scaldaferri F, Orlando A, Testa A, Pugliese D, Armuzzi A. Privitera G, et al. Among authors: bezzio c. Adv Ther. 2026 Jun 30. doi: 10.1007/s12325-026-03675-4. Online ahead of print. Adv Ther. 2026. PMID: 42377738
Virtual chromoendoscopy with linked color imaging versus dye-chromoendoscopy in the surveillance of patients with long-standing colonic inflammatory bowel disease.
Gabbiadini R, Franchellucci G, Minini F, Dal Buono A, Privitera G, Spadaccini M, Migliorisi G, Petronio L, Farinola V, Di Martino A, Bezzio C, Hassan C, Repici A, Armuzzi A. Gabbiadini R, et al. Among authors: bezzio c. J Crohns Colitis. 2026 Jun 7;20(6):jjag085. doi: 10.1093/ecco-jcc/jjag085. J Crohns Colitis. 2026. PMID: 42315966 Free PMC article.
New Technologies for IBD Endoscopy.
Bezzio C, Farinola V, Privitera G, Dal Buono A, Gabbiadini R, Loy L, Franchellucci G, Bartolotta E, Migliorisi G, Armuzzi A. Bezzio C, et al. J Clin Med. 2026 Mar 26;15(7):2539. doi: 10.3390/jcm15072539. J Clin Med. 2026. PMID: 41976841 Free PMC article. Review.
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.
Scaldaferri F, Di Vincenzo F, Aloi M, Ascolani M, Balestrieri P, Bertani L, Bezzio C, Bodini G, Bossa F, Calabrese E, Cannatelli R, Caprioli F, Cappello M, Cicala M, D'Amico F, Danese S, De Bernardi A, De Filippo FR, Desideri F, Di Paolo D, Di Sario A, Fantini MC, Ferracane C, Festa S, Fiorino G, Gabbiadini R, Geccherle A, Gerardi V, Giangreco E, Gravina AG, Laterza L, Lopetuso LR, Marafini I, Mastronardi M, Mendolaro M, Merli M, Mocci G, Onali S, Onidi MF, Pastorelli L, Piagnani A, Principi MB, Pugliese D, Ribaldone DG, Rispo A, Rizzello F, Santagata F, Savarino EV, Spagnuolo R, Tursi A, Panarese A, Mazzuoli S, Variola A, Viganò C, Armuzzi A; RESOLVE Study Group. Scaldaferri F, et al. Among authors: bezzio c. Am J Gastroenterol. 2026 Feb 18. doi: 10.14309/ajg.0000000000003969. Online ahead of print. Am J Gastroenterol. 2026. PMID: 41705712 Free article.
Building a Robust Investigator-Initiated Platform: The I-CARE Experience.
Kirchgesner J, Beaugerie L, Baumann C, Baert F, Rahier JF, Bergemalm D, Cañete F, Caron B, Cossignani M, Dias S, Farkas K, Girod P, Goren I, Holvoet T, Krasz S, Kumar A, Rimmer P, Sheridan J, Thut J, Uzzan M, Viazis N, Weimers P, Zagórowicz E, Buisson A, Avedano L, Rousseau H, Peyrin-Biroulet L, Sebastian S; I‐CARE Collaborator Group. Kirchgesner J, et al. Clin Pharmacol Ther. 2026 Jun;119(6):1537-1546. doi: 10.1002/cpt.70231. Epub 2026 Feb 15. Clin Pharmacol Ther. 2026. PMID: 41693257 Free PMC article.
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study.
Scalvini D, Maimaris S, Stasi E, Valvano M, Brinch D, Romeo M, Dota M, Dallio M, Gregorio V, Sabbione CS, Vernero M, Santacroce G, Mazza S, Agazzi S, Mauro A, Federico A, Schiepatti A, Ribaldone DG, Lenti MV, Manes G, Facciorusso A, Di Sabatino A, Biagi F, Bezzio C, Saibeni S, Anderloni A. Scalvini D, et al. Among authors: bezzio c. Diagnostics (Basel). 2026 Feb 5;16(3):490. doi: 10.3390/diagnostics16030490. Diagnostics (Basel). 2026. PMID: 41681808 Free PMC article.
Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-line Therapy in Anti-tumor Necrosis Factor-experienced Patients With Ulcerative Colitis.
Privitera G, Bezzio C, Figlioli G, D'Amico F, Mendes J, Varca S, Zingone F, Rodriguez-Lago I, Onali S, Caprioli FA, Chaparro M, Barreiro-de-Acosta M, Karmiris K, Degabli NT, Dar L, Pastorelli L, Gutiérrez A, Orlando A, Zabana Y, Saibeni S, Piovani D, Savarino EV, Pugliese D, Magro F, Danese S, Armuzzi A; PODIUM Study Group. Privitera G, et al. Among authors: bezzio c. Clin Gastroenterol Hepatol. 2026 Jan 29:S1542-3565(26)00045-5. doi: 10.1016/j.cgh.2026.01.017. Online ahead of print. Clin Gastroenterol Hepatol. 2026. PMID: 41616901 Free article.
139 results